These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 3698173)
1. Pharmacokinetic basis for the comparative antitumour activity and toxicity of chlorambucil, phenylacetic acid mustard and beta, beta-difluorochlorambucil (CB 7103) in mice. Lee FY; Coe P; Workman P Cancer Chemother Pharmacol; 1986; 17(1):21-9. PubMed ID: 3698173 [TBL] [Abstract][Full Text] [Related]
2. Altered pharmacokinetics in the mechanism of chemosensitization: effects of nitroimidazoles and other chemical modifiers on the pharmacokinetics, antitumour activity and acute toxicity of selected nitrogen mustards. Lee FY; Workman P Cancer Chemother Pharmacol; 1986; 17(1):30-7. PubMed ID: 3698174 [TBL] [Abstract][Full Text] [Related]
3. The metabolism of deuterated analogues of chlorambucil by the rat. Farmer PB; Foster AB; Jarman M; Newell DR; Oddy MR; Kiburis JH Chem Biol Interact; 1979 Dec; 28(2-3):211-24. PubMed ID: 549741 [TBL] [Abstract][Full Text] [Related]
4. Studies on the pharmacokinetics of chlorambucil and prednimustine in patients using a new high-performance liquid chromatographic assay. Oppitz MM; Musch E; Malek M; Rüb HP; von Unruh GE; Loos U; Mühlenbruch B Cancer Chemother Pharmacol; 1989; 23(4):208-12. PubMed ID: 2924378 [TBL] [Abstract][Full Text] [Related]
5. High-performance liquid chromatographic analysis of chlorambucil tert.-butyl ester and its active metabolites chlorambucil and phenylacetic mustard in plasma and tissue. Greig NH; Stahle PL; Shetty HU; Genka S; John V; Soncrant TT; Rapoport SI J Chromatogr; 1990 Dec; 534():279-86. PubMed ID: 2094719 [No Abstract] [Full Text] [Related]
6. Pharmacokinetics of chlorambucil-tertiary butyl ester, a lipophilic chlorambucil derivative that achieves and maintains high concentrations in brain. Greig NH; Daly EM; Sweeney DJ; Rapoport SI Cancer Chemother Pharmacol; 1990; 25(5):320-5. PubMed ID: 2306791 [TBL] [Abstract][Full Text] [Related]
7. Effect of food on pharmacokinetics of chlorambucil and its main metabolite, phenylacetic acid mustard. Ehrsson H; Wallin I; Simonsson B; Hartvig P; Oberg G Eur J Clin Pharmacol; 1984; 27(1):111-4. PubMed ID: 6489421 [TBL] [Abstract][Full Text] [Related]
8. Chlornaphazine and chlorambucil induce dominant lethal mutations in male mice. Barnett LB; Lewis SE Mutat Res; 2003 Mar; 543(2):145-54. PubMed ID: 12644184 [TBL] [Abstract][Full Text] [Related]
9. Comparative brain and plasma pharmacokinetics and anticancer activities of chlorambucil and melphalan in the rat. Greig NH; Sweeney DJ; Rapoport SI Cancer Chemother Pharmacol; 1988; 21(1):1-8. PubMed ID: 3342460 [TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationship of a series of nitrogen mustard- and pyrrole-containing minor groove-binding agents related to distamycin. Wyatt MD; Garbiras BJ; Haskell MK; Lee M; Souhami RL; Hartley JA Anticancer Drug Des; 1994 Dec; 9(6):511-25. PubMed ID: 7880376 [TBL] [Abstract][Full Text] [Related]
11. The pharmacokinetics of prednimustine and chlorambucil in the rat. Newell DR; Shepherd CR; Harrap KR Cancer Chemother Pharmacol; 1981; 6(1):85-91. PubMed ID: 7273268 [TBL] [Abstract][Full Text] [Related]
12. Development of lipophilic anticancer agents for the treatment of brain tumors by the esterification of water-soluble chlorambucil. Genka S; Deutsch J; Shetty UH; Stahle PL; John V; Lieberburg IM; Ali-Osman F; Rapoport SI; Greig NH Clin Exp Metastasis; 1993 Mar; 11(2):131-40. PubMed ID: 8444006 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and metabolism of the nitrogen mustard bioreductive drug 5. Kestell P; Pruijn FB; Siim BG; Palmer BD; Wilson WR Cancer Chemother Pharmacol; 2000; 46(5):365-74. PubMed ID: 11127940 [TBL] [Abstract][Full Text] [Related]
14. Comparative physico-chemical properties, biological effects, and disposition in mice of four nitrogen mustards. Godenèche D; Madelmont JC; Moreau MF; Plagne R; Meyniel G Cancer Chemother Pharmacol; 1980; 5(1):1-9. PubMed ID: 7460189 [TBL] [Abstract][Full Text] [Related]
15. The cytotoxicity, DNA crosslinking ability and DNA sequence selectivity of the aniline mustards melphalan, chlorambucil and 4-[bis(2-chloroethyl)amino] benzoic acid. Sunters A; Springer CJ; Bagshawe KD; Souhami RL; Hartley JA Biochem Pharmacol; 1992 Jul; 44(1):59-64. PubMed ID: 1632839 [TBL] [Abstract][Full Text] [Related]
16. Kinetics of chlorambucil in vitro: effects of fluid matrix, human gastric juice, plasma proteins and red cells. Löf K; Hovinen J; Reinikainen P; Vilpo LM; Seppälä E; Vilpo JA Chem Biol Interact; 1997 Mar; 103(3):187-98. PubMed ID: 9134009 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and pharmacodynamics of chlorambucil delivered in parenteral emulsion. Ganta S; Paxton JW; Baguley BC; Garg S Int J Pharm; 2008 Aug; 360(1-2):115-21. PubMed ID: 18508212 [TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of a nitrogen mustard derivative stabilized by apo-neocarzinostatin. Urbaniak MD; Bingham JP; Hartley JA; Woolfson DN; Caddick S J Med Chem; 2004 Sep; 47(19):4710-5. PubMed ID: 15341486 [TBL] [Abstract][Full Text] [Related]
19. Studies on the pharmacokinetics of chlorambucil and prednimustine in man. Newell DR; Calvert AH; Harrap KR; McElwain TJ Br J Clin Pharmacol; 1983 Feb; 15(2):253-8. PubMed ID: 6849759 [TBL] [Abstract][Full Text] [Related]
20. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice. Beland FA Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]